Drug Profile
OAM 71232
Latest Information Update: 18 Nov 2003
Price :
$50
*
At a glance
- Originator Nonindustrial source; Unknown
- Developer Nonindustrial source
- Class Anticoagulants
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 18 Nov 2003 Discontinued - Preclinical for Thrombosis in Japan (unspecified route)
- 06 Nov 1997 No-Development-Reported for Thrombosis in Japan (Unknown route)
- 24 Oct 1994 Preclinical development for Thrombosis in Japan (Unknown route)